Edition:
United States

Sangamo Therapeutics Inc (SGMO.OQ)

SGMO.OQ on NASDAQ Stock Exchange Global Select Market

11.74USD
3:59pm EST
Change (% chg)

$0.06 (+0.51%)
Prev Close
$11.68
Open
$11.95
Day's High
$11.95
Day's Low
$11.57
Volume
426,936
Avg. Vol
556,199
52-wk High
$27.50
52-wk Low
$9.00

Chart for

About

Sangamo Therapeutics, Inc., formerly Sangamo BioSciences, Inc., is a clinical-stage biotechnology company. The Company is focused on translating science into genomic therapies that transform patients' lives using the Company's platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The Company... (more)

Overall

Beta: 3.12
Market Cap(Mil.): $1,333.59
Shares Outstanding(Mil.): 83.61
Dividend: --
Yield (%): --

Financials

  SGMO.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.81 -- --
ROI: -28.31 0.29 15.02
ROE: -32.60 0.94 16.60

BioMarin sets stage early for hemophilia cure off-Broadway

(This version of the November 21st story has been refiled to show in paragraph 23 that Sangamo Therapeutics has six people in clinical trials)

Nov 22 2018

Earnings vs. Estimates